Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-κB signaling pathway
Yu, Chao, Chen, Shiyu, Guo, Yuntao, Sun, ChengyiVolume:
8
Year:
2018
Language:
english
Journal:
Theranostics
DOI:
10.7150/thno.23259
File:
PDF, 2.74 MB
english, 2018